HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ecthyma gangrenosum: survival with individualized antibiotic therapy.

Abstract
Five burn patients with ecthyma gangrenosum were treated with gentamicin sulfate in an individualized aminoglycoside regimen. Dosages greater than the currently recommended 3 to 5 mg/kg/day were necessary and ranged from 15 to 30 mg/kg/day. These increased dosages cannot be used routinely but only as serum level data indicate the need. Four of the five patients survived their course of ecthyma gangrenosum. The single fatality received a much smaller dosage of gentamicin as compared with the other four patients. No ototoxic or nephrotoxic reactions were noted in any of the patients.
AuthorsL D Solem, D Zaske, R G Strate
JournalArchives of surgery (Chicago, Ill. : 1960) (Arch Surg) Vol. 114 Issue 5 Pg. 580-3 (May 1979) ISSN: 0004-0010 [Print] United States
PMID444050 (Publication Type: Journal Article)
Chemical References
  • Gentamicins
  • Carbenicillin
Topics
  • Adolescent
  • Burns (complications)
  • Carbenicillin (therapeutic use)
  • Child, Preschool
  • Ecthyma (blood, drug therapy, mortality)
  • Gangrene (blood, drug therapy, mortality)
  • Gentamicins (administration & dosage, therapeutic use)
  • Humans
  • Infant
  • Kidney (physiopathology)
  • Pseudomonas Infections (blood, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: